Thromboprophylaxis for Hip Revision Arthroplasty: Can We Use the Recommendations for Primary Hip Surgery? A Cohort Study
The risk of thromboembolic events after hip revision arthroplasty might be higher than in primary hip arthroplasty. However, evidence regarding the use of thromboprophylaxis in revisions is scarce. The purpose of this study is to determine whether thromboprophylaxis recommendations for primary arthr...
| Autores Principales: | , , , , , |
|---|---|
| Formato: | Artículo (Article) |
| Lenguaje: | Inglés (English) |
| Publicado: |
SAGE Publications Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://repository.urosario.edu.co/handle/10336/23665 https://doi.org/10.1177/1076029618820167 |
| id |
ir-10336-23665 |
|---|---|
| recordtype |
dspace |
| spelling |
ir-10336-236652022-05-02T12:37:21Z Thromboprophylaxis for Hip Revision Arthroplasty: Can We Use the Recommendations for Primary Hip Surgery? A Cohort Study Bautista, Maria Muskus, Meilyn Tafur, Daniela Bonilla, Guillermo Llinás, Adolfo Monsalvo, Daniel Anticoagulant agent Apixaban Dabigatran Enoxaparin Fondaparinux Rivaroxaban Anticoagulant agent Adult Aged Arthroplasty Article Body mass Cohort analysis Comparative study Computed tomographic angiography Controlled study Deep vein thrombosis Doppler flowmetry Female Hip arthroplasty Hip replacement Hip revision arthroplasty Hip surgery Hospitalization Human Lung embolism Lung ventilation Major clinical study Male Operation duration Osteoarthritis Prevalence Priority journal Retrospective study Thrombosis prevention Venous thromboembolism Middle aged Procedures Very elderly Adult Aged Aged, 80 and over Anticoagulants Cohort studies Female Humans Male Middle aged Retrospective studies Arthroplasty Blood transfusion Hip Prevention and control Reoperation Replacement Venous thromboembolism replacement hip Arthroplasty The risk of thromboembolic events after hip revision arthroplasty might be higher than in primary hip arthroplasty. However, evidence regarding the use of thromboprophylaxis in revisions is scarce. The purpose of this study is to determine whether thromboprophylaxis recommendations for primary arthroplasty produce similar results in hip revision arthroplasty. This comparative cohort study retrospectively analyzed consecutive patients undergoing primary hip arthroplasty and hip revision surgery between March 2004 and December 2015, who received thromboprophylaxis according to local clinical practice guidelines for primary hip arthroplasty. The prevalence of deep vein thrombosis and pulmonary embolism and the presence of major bleeding events were assessed during hospitalization and at 3 months after discharge and compared between groups. The overall prevalence of thromboembolic events in the hip revision surgery cohort and in the primary hip cohort was 1.62% and 1.35%, respectively (P =.801). The 38.4% of hip revision patients and 20.3% of primary hip patients presented major bleeding events. Thromboembolic disease outcomes with the use of a standardized thromboprophylaxis regimen were similar in both cohorts, regardless of the high variability of hip revision surgery and the increased risk of complications. Implementation of this regimen is recommended in patients requiring joint replacement revision surgery. © The Author(s) 2019. 2019 2020-05-26T00:04:11Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 10760296 https://repository.urosario.edu.co/handle/10336/23665 https://doi.org/10.1177/1076029618820167 eng info:eu-repo/semantics/openAccess application/pdf SAGE Publications Inc. instname:Universidad del Rosario |
| institution |
EdocUR - Universidad del Rosario |
| collection |
DSpace |
| language |
Inglés (English) |
| topic |
Anticoagulant agent Apixaban Dabigatran Enoxaparin Fondaparinux Rivaroxaban Anticoagulant agent Adult Aged Arthroplasty Article Body mass Cohort analysis Comparative study Computed tomographic angiography Controlled study Deep vein thrombosis Doppler flowmetry Female Hip arthroplasty Hip replacement Hip revision arthroplasty Hip surgery Hospitalization Human Lung embolism Lung ventilation Major clinical study Male Operation duration Osteoarthritis Prevalence Priority journal Retrospective study Thrombosis prevention Venous thromboembolism Middle aged Procedures Very elderly Adult Aged Aged, 80 and over Anticoagulants Cohort studies Female Humans Male Middle aged Retrospective studies Arthroplasty Blood transfusion Hip Prevention and control Reoperation Replacement Venous thromboembolism replacement hip Arthroplasty |
| spellingShingle |
Anticoagulant agent Apixaban Dabigatran Enoxaparin Fondaparinux Rivaroxaban Anticoagulant agent Adult Aged Arthroplasty Article Body mass Cohort analysis Comparative study Computed tomographic angiography Controlled study Deep vein thrombosis Doppler flowmetry Female Hip arthroplasty Hip replacement Hip revision arthroplasty Hip surgery Hospitalization Human Lung embolism Lung ventilation Major clinical study Male Operation duration Osteoarthritis Prevalence Priority journal Retrospective study Thrombosis prevention Venous thromboembolism Middle aged Procedures Very elderly Adult Aged Aged, 80 and over Anticoagulants Cohort studies Female Humans Male Middle aged Retrospective studies Arthroplasty Blood transfusion Hip Prevention and control Reoperation Replacement Venous thromboembolism replacement hip Arthroplasty Bautista, Maria Muskus, Meilyn Tafur, Daniela Bonilla, Guillermo Llinás, Adolfo Monsalvo, Daniel Thromboprophylaxis for Hip Revision Arthroplasty: Can We Use the Recommendations for Primary Hip Surgery? A Cohort Study |
| description |
The risk of thromboembolic events after hip revision arthroplasty might be higher than in primary hip arthroplasty. However, evidence regarding the use of thromboprophylaxis in revisions is scarce. The purpose of this study is to determine whether thromboprophylaxis recommendations for primary arthroplasty produce similar results in hip revision arthroplasty. This comparative cohort study retrospectively analyzed consecutive patients undergoing primary hip arthroplasty and hip revision surgery between March 2004 and December 2015, who received thromboprophylaxis according to local clinical practice guidelines for primary hip arthroplasty. The prevalence of deep vein thrombosis and pulmonary embolism and the presence of major bleeding events were assessed during hospitalization and at 3 months after discharge and compared between groups. The overall prevalence of thromboembolic events in the hip revision surgery cohort and in the primary hip cohort was 1.62% and 1.35%, respectively (P =.801). The 38.4% of hip revision patients and 20.3% of primary hip patients presented major bleeding events. Thromboembolic disease outcomes with the use of a standardized thromboprophylaxis regimen were similar in both cohorts, regardless of the high variability of hip revision surgery and the increased risk of complications. Implementation of this regimen is recommended in patients requiring joint replacement revision surgery. © The Author(s) 2019. |
| format |
Artículo (Article) |
| author |
Bautista, Maria Muskus, Meilyn Tafur, Daniela Bonilla, Guillermo Llinás, Adolfo Monsalvo, Daniel |
| author_facet |
Bautista, Maria Muskus, Meilyn Tafur, Daniela Bonilla, Guillermo Llinás, Adolfo Monsalvo, Daniel |
| author_sort |
Bautista, Maria |
| title |
Thromboprophylaxis for Hip Revision Arthroplasty: Can We Use the Recommendations for Primary Hip Surgery? A Cohort Study |
| title_short |
Thromboprophylaxis for Hip Revision Arthroplasty: Can We Use the Recommendations for Primary Hip Surgery? A Cohort Study |
| title_full |
Thromboprophylaxis for Hip Revision Arthroplasty: Can We Use the Recommendations for Primary Hip Surgery? A Cohort Study |
| title_fullStr |
Thromboprophylaxis for Hip Revision Arthroplasty: Can We Use the Recommendations for Primary Hip Surgery? A Cohort Study |
| title_full_unstemmed |
Thromboprophylaxis for Hip Revision Arthroplasty: Can We Use the Recommendations for Primary Hip Surgery? A Cohort Study |
| title_sort |
thromboprophylaxis for hip revision arthroplasty: can we use the recommendations for primary hip surgery? a cohort study |
| publisher |
SAGE Publications Inc. |
| publishDate |
2019 |
| url |
https://repository.urosario.edu.co/handle/10336/23665 https://doi.org/10.1177/1076029618820167 |
| _version_ |
1740172252300705792 |
| score |
12,131701 |